{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:14:53Z","timestamp":1790082893339,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T00:00:00Z","timestamp":1609113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T00:00:00Z","timestamp":1609113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Polymyalgia rheumatica (PMR) can be difficult to diagnose. Whole-body [18F]FDG-PET\/CT allows for a comprehensive evaluation of all relevant articular and extra-articular structures affected by PMR. We aimed to summarize current evidence on the diagnostic value of [18F]FDG-PET\/CT for a diagnosis of PMR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>PubMed\/MEDLINE and the Cochrane Library database were searched from inception through May 31, 2020. Studies containing patients with PMR who underwent [18F]FDG-PET\/CT were included. Screening and full-text review were performed by 3 investigators and data extraction by 2 investigators. Risk of bias was examined with the QUADAS-2 tool. Diagnostic test meta-analysis was performed with a bivariate model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twenty studies were included in the systematic review, of which 9 studies (<jats:italic>n<\/jats:italic>\u2009=\u2009636 patients) were eligible for meta-analysis. [18F]FDG positivity at the following sites was associated with a diagnosis of PMR: interspinous bursae (positive likelihood ratio (LR+) 4.00; 95% CI 1.84\u20138.71), hips (LR+ 2.91; 95% CI 2.09\u20134.05), ischial tuberosities (LR+ 2.86; 95% CI 1.91\u20134.28), shoulders (LR+ 2.57; 95% CI 1.24\u20135.32) and sternoclavicular joints (LR+ 2.31; 95% CI 1.33\u20134.02). Negative likelihood ratios (LR\u2212) for these sites, as well as the greater trochanters, were all less than 0.50. Composite [18F]FDG-PET\/CT scores, as reported in 3 studies, provided a pooled LR+ of 3.91 (95% CI 2.42\u20136.32) and LR\u2212 of 0.19 (95% CI 0.10\u20130.36). Moderate to high heterogeneity was observed across the studies, mainly due to differences in patient selection, scanning procedures and\/or interpretation criteria.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Significant [18F]FDG uptake at a combination of anatomic sites is informative for a diagnosis of PMR. [18F]FDG-PET\/CT might be an important diagnostic tool in patients with suspected PMR. This study also highlights the need for adherence to published procedural recommendations and standardized interpretation criteria for the use of [18F]FDG-PET\/CT in PMR.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00259-020-05162-6","type":"journal-article","created":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T22:02:28Z","timestamp":1609192948000},"page":"1876-1889","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Diagnostic value of [18F]FDG-PET\/CT in polymyalgia rheumatica: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"48","author":[{"given":"K. S. M.","family":"van der Geest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Treglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. W. J. M.","family":"Glaudemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Jamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. H. J. A.","family":"Slart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Gheysens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,28]]},"reference":[{"key":"5162_CR1","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/art.30155","volume":"63","author":"CS Crowson","year":"2011","unstructured":"Crowson CS, Matteson EL, Myasoedova E, Michet CJ, Ernste FC, Warrington KJ, et al. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum. 2011;63:633\u20139.","journal-title":"Arthritis Rheum"},{"key":"5162_CR2","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/S0140-6736(17)31825-1","volume":"390","author":"MA Gonz\u00e1lez-Gay","year":"2017","unstructured":"Gonz\u00e1lez-Gay MA, Matteson EL, Casta\u00f1eda S. Polymyalgia rheumatica. Lancet. 2017;390:1700\u201312.","journal-title":"Lancet."},{"key":"5162_CR3","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/rheumatology\/keu526","volume":"54","author":"KSM van der Geest","year":"2015","unstructured":"van der Geest KSM, Abdulahad WH, Rutgers A, Horst G, Bijzet J, Arends S, et al. Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica. Rheumatology. 2015;54:1397\u2013402.","journal-title":"Rheumatology."},{"key":"5162_CR4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1136\/annrheumdis-2011-200329","volume":"71","author":"B Dasgupta","year":"2012","unstructured":"Dasgupta B, Cimmino MA, Maradit-Kremers H, Schmidt WA, Schirmer M, Salvarani C, et al. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2012;71:484\u201392.","journal-title":"Ann Rheum Dis"},{"key":"5162_CR5","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1093\/rheumatology\/kep286","volume":"48","author":"P Macchioni","year":"2009","unstructured":"Macchioni P, Catanoso MG, Pipitone N, Boiardi L, Salvarani C. Longitudinal examination with shoulder ultrasound of patients with polymyalgia rheumatica. Rheumatology. 2009;48:1566\u20139.","journal-title":"Rheumatology."},{"key":"5162_CR6","doi-asserted-by":"publisher","first-page":"117954411774585","DOI":"10.1177\/1179544117745851","volume":"10","author":"T Suzuki","year":"2017","unstructured":"Suzuki T, Yoshida R, Hidaka Y, Seri Y. Proliferative synovitis of the shoulder bursae is a key feature for discriminating elderly onset rheumatoid arthritis mimicking polymyalgia rheumatica from polymyalgia rheumatica. Clin Med Insights Arthritis Musculoskelet Disord. 2017;10:117954411774585.","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"key":"5162_CR7","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1136\/annrheumdis-2015-207395","volume":"74","author":"SL Mackie","year":"2015","unstructured":"Mackie SL, Pease CT, Fukuba E, Harris E, Emery P, Hodgson R, et al. Whole-body MRI of patients with polymyalgia rheumatica identifies a distinct subset with complete patient-reported response to glucocorticoids. Ann Rheum Dis. 2015;74:2188\u201392.","journal-title":"Ann Rheum Dis"},{"key":"5162_CR8","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3899\/jrheum.180958","volume":"46","author":"J-P Laporte","year":"2019","unstructured":"Laporte J-P, Garrigues F, Huwart A, Jousse-Joulin S, Marhadour T, Guellec D, et al. Localized myofascial inflammation revealed by magnetic resonance imaging in recent-onset polymyalgia rheumatica and effect of tocilizumab therapy. J Rheumatol. 2019;46:1619\u201326.","journal-title":"J Rheumatol"},{"key":"5162_CR9","first-page":"S86","volume":"36","author":"B Fruth","year":"2018","unstructured":"Fruth B, Buehring B, Baraliakos X, Braun J. Use of contrast-enhanced magnetic resonance imaging of the pelvis to describe changes at different anatomic sites which are potentially specific for polymyalgia rheumatica. Clin Exp Rheumatol. 2018;36:S86\u201395.","journal-title":"Clin Exp Rheumatol"},{"key":"5162_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13075-017-1499-2","volume":"20","author":"A Huwart","year":"2018","unstructured":"Huwart A, Garrigues F, Jousse-Joulin S, Marhadour T, Guellec D, Cornec D, et al. Ultrasonography and magnetic resonance imaging changes in patients with polymyalgia rheumatica treated by tocilizumab. Arthritis Res Ther. 2018;20:11.","journal-title":"Arthritis Res Ther"},{"key":"5162_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/623036","volume":"2013","author":"AWJM Glaudemans","year":"2013","unstructured":"Glaudemans AWJM, de Vries EFJ, Galli F, Dierckx RAJO, Slart RHJA, Signore A. The use of (18)F-FDG-PET\/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases. Clin Dev Immunol. 2013;2013:1\u201314.","journal-title":"Clin Dev Immunol"},{"key":"5162_CR12","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1007\/s00259-018-3973-8","volume":"45","author":"RHJA Slart","year":"2018","unstructured":"Slart RHJA. FDG-PET\/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. Eur J Nucl Med Mol Imaging. 2018;45:1250\u201369.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5162_CR13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.bcmd.2003.09.002","volume":"32","author":"Y Fu","year":"2004","unstructured":"Fu Y, Maianu L, Melbert B, Garvey W. Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. Blood Cells Mol Dis. 2004;32:182\u201390.","journal-title":"Blood Cells Mol Dis"},{"key":"5162_CR14","first-page":"1301","volume":"36","author":"S Yamada","year":"1995","unstructured":"Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med. 1995;36:1301\u20136.","journal-title":"J Nucl Med"},{"key":"5162_CR15","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1053\/j.semnuclmed.2017.02.005","volume":"47","author":"K Kubota","year":"2017","unstructured":"Kubota K, Yamashita H, Mimori A. Clinical value of FDG-PET\/CT for the evaluation of rheumatic diseases: rheumatoid arthritis, polymyalgia rheumatica, and relapsing polychondritis. Semin Nucl Med. 2017;47:408\u201324.","journal-title":"Semin Nucl Med"},{"key":"5162_CR16","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/annrheumdis-2017-212649","volume":"77","author":"C Dejaco","year":"2018","unstructured":"Dejaco C, Ramiro S, Duftner C, Besson FL, Bley TA, Blockmans D, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis. 2018;77:636\u201343.","journal-title":"Ann Rheum Dis"},{"key":"5162_CR17","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/jama.2017.19163","volume":"319","author":"MDF McInnes","year":"2018","unstructured":"McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM, Clifford T, et al. Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies. JAMA. 2018;319:388.","journal-title":"JAMA."},{"key":"5162_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes A, Westwood M. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529\u2013236.","journal-title":"Ann Intern Med"},{"key":"5162_CR19","doi-asserted-by":"crossref","unstructured":"Blockmans D, Maes A, Stroobants S, Nuyts J, Bormans G, Knockaert D, et al. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology. 1999.","DOI":"10.1093\/rheumatology\/38.5.444"},{"key":"5162_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/art.21699","volume":"55","author":"D Blockmans","year":"2006","unstructured":"Blockmans D, De Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Care Res. 2006;55:131\u20137.","journal-title":"Arthritis Care Res"},{"key":"5162_CR21","doi-asserted-by":"crossref","unstructured":"Camellino D, Paparo F, Morbelli S, Cutolo M, Sambuceti G, Cimmino MA. Interspinous bursitis is common in polymyalgia rheumatica, but is not associated with spinal pain. Arthritis Res Ther. BioMed Central Ltd.; 2014;16.","DOI":"10.1186\/s13075-014-0492-2"},{"key":"5162_CR22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s10067-018-3988-3","volume":"37","author":"A Charpentier","year":"2018","unstructured":"Charpentier A, Verhoeven F, Sondag M, Guillot X, Prati C, Wendling D. Therapeutic response to prednisone in relation to age in polymyalgia rheumatica: a comparison study. Clin Rheumatol. Springer London. 2018;37:819\u201323.","journal-title":"Clin Rheumatol"},{"key":"5162_CR23","first-page":"1865","volume":"52","author":"MA Cimmino","year":"2013","unstructured":"Cimmino MA, Camellino D, Paparo F, Morbelli S, Massollo M, Cutolo M, et al. High frequency of capsular knee involvement in polymyalgia rheumatica\/giant cell arteritis patients studied by positron emission tomography. Rheumatol (United Kingdom). Oxford University Press. 2013;52:1865\u201372.","journal-title":"Rheumatol (United Kingdom)"},{"key":"5162_CR24","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1136\/annrheumdis-2015-208742","volume":"75","author":"V Devauchelle-Pensec","year":"2016","unstructured":"Devauchelle-Pensec V, Berthelot JM, Cornec D, Renaudineau Y, Marhadour T, Jousse-Joulin S, et al. Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study. Ann Rheum DisBMJ Publishing Group. 2016;75:1506\u201310.","journal-title":"Ann Rheum Dis"},{"key":"5162_CR25","first-page":"1908","volume":"57","author":"L Henckaerts","year":"2018","unstructured":"Henckaerts L, Gheysens O, Vanderschueren S, Goffin K, Blockmans D. Use of 18 f-fluorodeoxyglucose positron emission tomography in the diagnosis of polymyalgia rheumatica \u2014 a prospective study of 99 patients. Rheumatol (United Kingdom). Oxford University Press. 2018;57:1908\u201316.","journal-title":"Rheumatol (United Kingdom)"},{"key":"5162_CR26","doi-asserted-by":"crossref","unstructured":"Horikoshi H, Nakanishi T, Tamura K, Kimura F, Itoh K. 18F-fluorodeoxyglucose-positron emission tomography\/computed tomography for the diagnosis of polymyalgia-like illnesses: a retrospective study. BMC Rheumatol. BioMed Central Ltd.; 2020;4.","DOI":"10.1186\/s41927-020-00121-y"},{"key":"5162_CR27","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1080\/14397595.2019.1591065","volume":"30","author":"K Kaneko","year":"2020","unstructured":"Kaneko K, Suematsu E, Miyamura T, Ishioka H. Differences of articular and extra-articular involvement in polymyalgia rheumatica: a comparison by whole-body FDG-PET\/CT. Mod Rheumatol Taylor and Francis Ltd. 2020;30:358\u201364.","journal-title":"Mod Rheumatol"},{"key":"5162_CR28","first-page":"A5410","volume":"64","author":"A Lund-Petersen","year":"2017","unstructured":"Lund-Petersen A, Voss A, Laustrup H. PET-CT findings in patients with polymyalgia rheumatica without symptoms of cranial ischaemia. Dan Med J. 2017;64:A5410.","journal-title":"Dan Med J"},{"key":"5162_CR29","first-page":"345","volume":"57","author":"CE Owen","year":"2018","unstructured":"Owen CE, Poon AMT, Lee ST, Yap LP, Zwar RB, McMenamin CM, et al. Fusion of positron emission tomography\/computed tomography with magnetic resonance imaging reveals hamstring peritendonitis in polymyalgia rheumatica. Rheumatol (United Kingdom). Oxford University Press. 2018;57:345\u201353.","journal-title":"Rheumatol (United Kingdom)"},{"key":"5162_CR30","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/s00259-020-04731-z","volume":"47","author":"CE Owen","year":"2020","unstructured":"Owen CE, Poon AMT, Yang V, McMaster C, Lee ST, Liew DFL, et al. Abnormalities at three musculoskeletal sites on whole-body positron emission tomography\/computed tomography can diagnose polymyalgia rheumatica with high sensitivity and specificity. Eur J Nucl Med Mol Imaging Springer. 2020;47:2461\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5162_CR31","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00259-015-3287-z","volume":"43","author":"X Palard-Novello","year":"2016","unstructured":"Palard-Novello X, Querellou S, Gouillou M, Saraux A, Marhadour T, Garrigues F, et al. Value of 18F-FDG PET\/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment. Eur J Nucl Med Mol Imaging. Springer Berlin. 2016;43:773\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5162_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1515\/raon-2017-0001","volume":"51","author":"Z Rehak","year":"2017","unstructured":"Rehak Z, Sprlakova-Pukova A, Bortlicek Z, Fojtik Z, Kazda T, Joukal M, et al. PET\/CT imaging in polymyalgia rheumatica: praepubic 18F-FDG uptake correlates with pectineus and adductor longus muscles enthesitis and with tenosynovitis. Radiol Oncol Association of Radiology and Oncology. 2017;51:8\u201314.","journal-title":"Radiol Oncol"},{"key":"5162_CR33","doi-asserted-by":"publisher","first-page":"629","DOI":"10.5507\/bp.2015.026","volume":"159","author":"Z Rehak","year":"2015","unstructured":"Rehak Z, Vasina J, Nemec P, Fojtik Z, Koukalova R, Bortlicek Z, et al. Various forms of18F-FDG PET and PET\/CT findings in patients with polymyalgia rheumatica. Biomed Pap PALACKY UNIV. 2015;159:629\u201336.","journal-title":"Biomed Pap"},{"key":"5162_CR34","first-page":"1452","volume":"55","author":"M Sondag","year":"2016","unstructured":"Sondag M, Guillot X, Verhoeven F, Blagosklonov O, Prati C, Boulahdour H, et al. Utility of 18F-fluoro-dexoxyglucose positron emission tomography for the diagnosis of polymyalgia rheumatica: a controlled study. Rheumatol (United Kingdom). Oxford University Press. 2016;55:1452\u20137.","journal-title":"Rheumatol (United Kingdom)"},{"key":"5162_CR35","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3109\/14397595.2014.978936","volume":"25","author":"H Takahashi","year":"2015","unstructured":"Takahashi H, Yamashita H, Kubota K, Miyata Y, Okasaki M, Morooka M, et al. Differences in fluorodeoxyglucose positron emission tomography\/computed tomography findings between elderly onset rheumatoid arthritis and polymyalgia rheumatica. Mod Rheumatol Informa Healthcare. 2015;25:546\u201351.","journal-title":"Mod Rheumatol"},{"key":"5162_CR36","doi-asserted-by":"crossref","unstructured":"Wakura D, Kotani T, Takeuchi T, Komori T, Yoshida S, Makino S, et al. Differentiation between polymyalgia rheumatica (PMR) and elderly-onset rheumatoid arthritis using 18F-fluorodeoxyglucose positron emission tomography\/computed tomography: is enthesitis a new pathological lesion in PMR? PLoS One Public Library of Science. 2016;11.","DOI":"10.1371\/journal.pone.0158509"},{"key":"5162_CR37","doi-asserted-by":"crossref","unstructured":"Wendling D, Sondag M, Giraud N, Chouk M, Boulahdour H, Prati C, et al. Muscle involvement on 18F-FDG PET-CT in polymyalgia rheumatica. a controlled retrospective study of 101 patients. Jt Bone Spine. Elsevier Masson SAS2020;87:225\u20138.","DOI":"10.1016\/j.jbspin.2020.01.006"},{"key":"5162_CR38","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jbspin.2012.04.006","volume":"80","author":"H Yamashita","year":"2013","unstructured":"Yamashita H, Kubota K, Takahashi Y, Minamimoto R, Morooka M, Kaneko H, et al. Similarities and differences in fluorodeoxyglucose positron emission tomography\/computed tomography findings in spondyloarthropathy, polymyalgia rheumatica and rheumatoid arthritis. Jt Bone Spine. 2013;80:171\u20137.","journal-title":"Jt Bone Spine"},{"key":"5162_CR39","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3109\/s10165-011-0581-x","volume":"22","author":"H Yamashita","year":"2012","unstructured":"Yamashita H, Kubota K, Takahashi Y, Minaminoto R, Morooka M, Ito K, et al. Whole-body fluorodeoxyglucose positron emission tomography\/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis. Mod Rheumatol. 2012;22:705\u201311.","journal-title":"Mod Rheumatol"},{"key":"5162_CR40","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s12149-018-1269-5","volume":"32","author":"S Yuge","year":"2018","unstructured":"Yuge S, Nakatani K, Yoshino K, Koyama T. Diagnosing polymyalgia rheumatica on 18F-FDG PET\/CT: typical uptake patterns. Ann Nucl Med Springer Tokyo. 2018;32:573\u20137.","journal-title":"Ann Nucl Med"},{"key":"5162_CR41","doi-asserted-by":"crossref","unstructured":"Bird HA, Esselinckx W, Dixon SAJ, Mowat AG, Wood PH. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis. 1979:434\u20139.","DOI":"10.1136\/ard.38.5.434"},{"key":"5162_CR42","doi-asserted-by":"crossref","unstructured":"Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica. a 10-year epidemiologic and clinical study. Ann Intern Med. 1982;672\u201380.","DOI":"10.7326\/0003-4819-97-5-672"},{"key":"5162_CR43","doi-asserted-by":"crossref","unstructured":"Healey LA. Long-term follow-up of polymyalgia rheumatica: evidence for synovitis. Semin Arthritis Rheum. 1984:322\u20138.","DOI":"10.1016\/0049-0172(84)90012-X"},{"key":"5162_CR44","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1097\/MNM.0000000000001292","volume":"41","author":"K Kim","year":"2020","unstructured":"Kim K, Kim S-J. Diagnostic performance of F-18 fluorodeoxyglucose PET\/computed tomography for diagnosis of polymyalgia rheumatica: a meta-analysis. Nucl Med Commun. 2020;41:1313\u201321.","journal-title":"Nucl Med Commun"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-020-05162-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-020-05162-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-020-05162-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T21:04:32Z","timestamp":1620767072000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-020-05162-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,28]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["5162"],"URL":"https:\/\/doi.org\/10.1007\/s00259-020-05162-6","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,28]]},"assertion":[{"value":"16 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. van der Geest has received a speaker fee from Roche paid to the UMCG. Dr. Brouwer has received consultancy and speaker fees from Roche paid to the UMCG. The other authors have no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not required since no human participants or animals were recruited for the current study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}